2022
DOI: 10.3389/fimmu.2021.794780
|View full text |Cite
|
Sign up to set email alerts
|

In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor

Abstract: Various metabolites identified with therapeutic mushrooms have been found from different sources and are known to have antibacterial, antiviral, and anticancer properties. Over thousands soil growth-based mushroom metabolites have been discovered, and utilized worldwide to combat malignancy. In this study, psilocybin-mushroom that contains the psychedelic compounds such as psilacetin, psilocin, and psilocybine were screened and found to be inhibitors of SARS-CoV-2 Mprotease. It has been found that psilacetin, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 44 publications
0
7
0
Order By: Relevance
“…The protein-ligand interaction of docked complexes was presented in two dimensions for interaction analysis of the protein-ligand complex by using LigPlus ( Ahmad et al, 2022 ). The proteins, ligands, and their binding pockets for the protein’s three-dimensional structure were generated using PyMol ( Ahmad et al, 2014 ; Hassan et al, 2014 ; Baig et al, 2016 ; Khan et al, 2016 ; Khan et al, 2021 ; Khan et al, 2022a ; Khan et al, 2022b ).…”
Section: Methodsmentioning
confidence: 99%
“…The protein-ligand interaction of docked complexes was presented in two dimensions for interaction analysis of the protein-ligand complex by using LigPlus ( Ahmad et al, 2022 ). The proteins, ligands, and their binding pockets for the protein’s three-dimensional structure were generated using PyMol ( Ahmad et al, 2014 ; Hassan et al, 2014 ; Baig et al, 2016 ; Khan et al, 2016 ; Khan et al, 2021 ; Khan et al, 2022a ; Khan et al, 2022b ).…”
Section: Methodsmentioning
confidence: 99%
“…Psilacetin, psilocin, and psilocybine, which are psilocybin-mushroom components, have been subjected to M pro SARS-CoV-2 docking studies (PDB: 6LU7) utilizing AutoDock and AutoDock vina software. They reveal considerable binding affinity in the protein active site (interaction docking scores = −6.0, −5.4, −5.8 kcal/mol for psilacetin, psilocin, and psilocybine, respectively) [ 159 ] ( Figure 25 and Figure 26 ).…”
Section: In Silico Predicted Anti-sars-cov-2 Indolesmentioning
confidence: 99%
“… 2D- and 3D-docking interactions of ( A , B ), N3 inhibitor; ( C , D ), psilacetin; ( E , F ), psilocin; and ( G , H ), psilocybine in the active pocket of M pro SARS-CoV-2 (PDB: 6LU7) [ 159 ]. …”
Section: Figures and Schemesmentioning
confidence: 99%
“…The results are described in 280 articles and 101 patents that contain the term "psilocin", as well as 924 articles and 176 patents for "psilocybin", as can be found for this period in the Scifinder database. Indeed, psilocin-mushrooms containing psilocin (64), psilocybin (65), and psilacetin (66, Figure 5) have been suggested as viable chemotherapeutic agents against SARS-CoV-2 [107].…”
Section: Indolesmentioning
confidence: 99%